Xact Kapitalforvaltning’s Genomic Health, Inc. GHDX Stock Holding History

Xact Kapitalforvaltning’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,900	Closed	-$332K	–	1450
2019 Q3	$332K	Hold	4,900	–	–	0.01%	1147
2019 Q2	$285K	Hold	4,900	–	–	0.01%	1264
2019 Q1	$343K	Buy	+4,900	New	+$363K	0.01%	1149

Xact Kapitalforvaltning's GHDX Position: Q4 2019 in Review

Xact Kapitalforvaltning sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,900 shares — an estimated $332K sold.

Xact Kapitalforvaltning first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $343K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Xact Kapitalforvaltning reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Xact Kapitalforvaltning sold 4,900 Genomic Health, Inc. shares in Q4 2019, an estimated $332K.
Xact Kapitalforvaltning first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
Xact Kapitalforvaltning's Genomic Health, Inc. position peaked at $343K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.